<DOC>
	<DOCNO>NCT02940314</DOCNO>
	<brief_summary>The purpose study compare safety pharmacokinetic characteristic administration HIP1503 HGP1103 healthy male volunteer .</brief_summary>
	<brief_title>Safety Pharmacokinetic Characteristics After Administration HIP1503 HGP1103 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>1 . Healthy male volunteer , age 19 45 year . 2 . The result Body Mass Index ( BMI ) 17.5 kg/m2~ 30.5 kg/m2 , body weight 55kg . 3 . Subjects ability comprehend objective , content study property study drug participate trial willingness sign inform consent writing . 1 . Presence medical history concurrent disease , include clinically significant disorder kidney , liver , cardiovascular system , respiratory system , endocrine system , neuropsychiatric system . 2 . Medical history Gastrointestinal Diseases effect drug absorption ( esophageal disease , chronic disease ) surgery ( except appendectomy , herniolaparotomy ) 3. sit SBP &gt; 140 mmHg , sit DBP &gt; 90 mmHg 4 . Alcohol Drug abuse within 1 year</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>